Exact Mass: 525.2838714
Exact Mass Matches: 525.2838714
Found 500 metabolites which its exact mass value is equals to given mass value 525.2838714,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Protoverine
D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents > D014704 - Veratrum Alkaloids D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents > D011526 - Protoveratrines
LysoPE(0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
LysoPE(0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
LysoPE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
LysoPE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
1-Stearoylglycerophosphoserine
C24H48NO9P (525.3066527999999)
1-Stearoylglycerophosphoserine is a phosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PS(18:0/0:0), in particular, consists of two octadecanoyl chains at positions C-1 and C-2. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE.
LysoPS(18:0/0:0)
C24H48NO9P (525.3066527999999)
LysoPS(18:0/0:0) is a lysophosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic. However, it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylserines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPS(18:0/0:0), in particular, consists of one chain of stearic acid at the C-1 position.
Spiropiperidine
Selpercatinib
Chondrochloren A
C27H40ClNO7 (525.2493160000001)
A monocarboxylic acid amide with formula C27H40ClNO7, that is produced by Chondromyces crocatus and exhibits antibiotic properties.
Ile Glu His Lys
Thr His Ile Arg
His Val Arg Asp
(2E,6E,12E)-19-(2-amino-2-oxoethyl)-9,11-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxohenicosa-2,6,12-trienedioic acid
14-Benzoyltalatizamine
Origin: Plant; SubCategory_DNP: Terpenoid alkaloids, Diterpene alkaloid, Delphinium alkaloid
(2E,6E,12E)-19-(2-amino-2-oxoethyl)-9,11-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxohenicosa-2,6,12-trienedioic acid [IIN-based on: CCMSLIB00000848219]
(2E,6E,12E)-19-(2-amino-2-oxoethyl)-9,11-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxohenicosa-2,6,12-trienedioic acid [IIN-based: Match]
Ala His Ile Trp
Ala His Leu Trp
Ala His Trp Ile
Ala His Trp Leu
Ala Ile His Trp
Ala Ile Trp His
Ala Leu His Trp
Ala Leu Trp His
Ala Trp His Ile
Ala Trp His Leu
Ala Trp Ile His
Ala Trp Leu His
Cys Ile Lys Tyr
Cys Ile Tyr Lys
Cys Lys Ile Tyr
Cys Lys Leu Tyr
Cys Lys Tyr Ile
Cys Lys Tyr Leu
Cys Leu Lys Tyr
Cys Leu Tyr Lys
Cys Tyr Ile Lys
Cys Tyr Lys Ile
Cys Tyr Lys Leu
Cys Tyr Leu Lys
Asp His Arg Val
Asp His Val Arg
Asp Arg His Val
Asp Arg Val His
Asp Val His Arg
Asp Val Arg His
Glu His Ile Lys
Glu His Ile Gln
C22H35N7O8 (525.2546990000001)
Glu His Lys Ile
Glu His Lys Leu
Glu His Leu Lys
Glu His Leu Gln
C22H35N7O8 (525.2546990000001)
Glu His Gln Ile
C22H35N7O8 (525.2546990000001)
Glu His Gln Leu
C22H35N7O8 (525.2546990000001)
Glu Ile His Lys
Glu Ile His Gln
C22H35N7O8 (525.2546990000001)
Glu Ile Lys His
Glu Ile Gln His
C22H35N7O8 (525.2546990000001)
Glu Lys His Ile
Glu Lys His Leu
Glu Lys Ile His
Glu Lys Leu His
Glu Leu His Lys
Glu Leu His Gln
C22H35N7O8 (525.2546990000001)
Glu Leu Lys His
Glu Leu Gln His
C22H35N7O8 (525.2546990000001)
Glu Gln His Ile
C22H35N7O8 (525.2546990000001)
Glu Gln His Leu
C22H35N7O8 (525.2546990000001)
Glu Gln Ile His
C22H35N7O8 (525.2546990000001)
Glu Gln Leu His
C22H35N7O8 (525.2546990000001)
Phe Phe Gly Arg
Phe Phe Asn Val
Phe Phe Arg Gly
Phe Phe Val Asn
Phe Gly Phe Arg
Phe Gly Arg Phe
Phe Lys Met Thr
Phe Lys Thr Met
Phe Met Lys Thr
Phe Met Thr Lys
Phe Asn Phe Val
Phe Asn Val Phe
Phe Arg Phe Gly
Phe Arg Gly Phe
Phe Thr Lys Met
Phe Thr Met Lys
Phe Val Phe Asn
Phe Val Asn Phe
Gly Phe Phe Arg
Gly Phe Arg Phe
Gly Arg Phe Phe
His Ala Ile Trp
His Ala Leu Trp
His Ala Trp Ile
His Ala Trp Leu
His Asp Arg Val
His Asp Val Arg
His Glu Ile Lys
His Glu Ile Gln
C22H35N7O8 (525.2546990000001)
His Glu Lys Ile
His Glu Lys Leu
His Glu Leu Lys
His Glu Leu Gln
C22H35N7O8 (525.2546990000001)
His Glu Gln Ile
C22H35N7O8 (525.2546990000001)
His Glu Gln Leu
C22H35N7O8 (525.2546990000001)
His Ile Ala Trp
His Ile Glu Lys
His Ile Glu Gln
C22H35N7O8 (525.2546990000001)
His Ile Lys Glu
His Ile Gln Glu
C22H35N7O8 (525.2546990000001)
His Ile Arg Thr
His Ile Thr Arg
His Ile Trp Ala
His Lys Glu Ile
His Lys Glu Leu
His Lys Ile Glu
His Lys Lys Asn
His Lys Leu Glu
His Lys Asn Lys
His Lys Asn Gln
His Lys Gln Asn
His Leu Ala Trp
His Leu Glu Lys
His Leu Glu Gln
C22H35N7O8 (525.2546990000001)
His Leu Lys Glu
His Leu Gln Glu
C22H35N7O8 (525.2546990000001)
His Leu Arg Thr
His Leu Thr Arg
His Leu Trp Ala
His Asn Lys Lys
His Asn Lys Gln
His Asn Gln Lys
His Gln Glu Ile
C22H35N7O8 (525.2546990000001)
His Gln Glu Leu
C22H35N7O8 (525.2546990000001)
His Gln Ile Glu
C22H35N7O8 (525.2546990000001)
His Gln Lys Asn
His Gln Leu Glu
C22H35N7O8 (525.2546990000001)
His Gln Asn Lys
His Arg Asp Val
His Arg Ile Thr
His Arg Leu Thr
His Arg Thr Ile
His Arg Thr Leu
His Arg Val Asp
His Thr Ile Arg
His Thr Leu Arg
His Thr Arg Ile
His Thr Arg Leu
His Val Asp Arg
His Trp Ala Ile
His Trp Ala Leu
His Trp Ile Ala
His Trp Leu Ala
Ile Ala His Trp
Ile Ala Trp His
Ile Cys Lys Tyr
Ile Cys Tyr Lys
Ile Glu His Gln
C22H35N7O8 (525.2546990000001)
Ile Glu Lys His
Ile Glu Gln His
C22H35N7O8 (525.2546990000001)
Ile His Ala Trp
Ile His Glu Lys
Ile His Glu Gln
C22H35N7O8 (525.2546990000001)
Ile His Lys Glu
Ile His Gln Glu
C22H35N7O8 (525.2546990000001)
Ile His Arg Thr
Ile His Thr Arg
Ile His Trp Ala
Ile Lys Cys Tyr
Ile Lys Glu His
Ile Lys His Glu
Ile Lys Tyr Cys
Ile Gln Glu His
C22H35N7O8 (525.2546990000001)
Ile Gln His Glu
C22H35N7O8 (525.2546990000001)
Ile Arg His Thr
Ile Arg Thr His
Ile Thr His Arg
Ile Thr Arg His
Ile Trp Ala His
Ile Trp His Ala
Ile Tyr Cys Lys
Ile Tyr Lys Cys
Lys Cys Ile Tyr
Lys Cys Leu Tyr
Lys Cys Tyr Ile
Lys Cys Tyr Leu
Lys Glu His Ile
Lys Glu His Leu
Lys Glu Ile His
Lys Glu Leu His
Lys Phe Met Thr
Lys Phe Thr Met
Lys His Glu Ile
Lys His Glu Leu
Lys His Ile Glu
Lys His Lys Asn
Lys His Leu Glu
Lys His Asn Lys
Lys His Asn Gln
Lys His Gln Asn
Lys Ile Cys Tyr
Lys Ile Glu His
Lys Ile His Glu
Lys Ile Tyr Cys
Lys Lys His Asn
Lys Lys Asn His
Lys Leu Cys Tyr
Lys Leu Glu His
Lys Leu His Glu
Lys Leu Tyr Cys
Lys Met Phe Thr
Lys Met Thr Phe
Lys Asn His Lys
Lys Asn His Gln
Lys Asn Lys His
Lys Asn Gln His
Lys Gln His Asn
Lys Gln Asn His
Lys Thr Phe Met
Lys Thr Met Phe
Lys Tyr Cys Ile
Lys Tyr Cys Leu
Lys Tyr Ile Cys
Lys Tyr Leu Cys
Leu Ala His Trp
Leu Ala Trp His
Leu Cys Lys Tyr
Leu Cys Tyr Lys
Leu Glu His Lys
Leu Glu His Gln
C22H35N7O8 (525.2546990000001)
Leu Glu Lys His
Leu Glu Gln His
C22H35N7O8 (525.2546990000001)
Leu His Ala Trp
Leu His Glu Lys
Leu His Glu Gln
C22H35N7O8 (525.2546990000001)
Leu His Lys Glu
Leu His Gln Glu
C22H35N7O8 (525.2546990000001)
Leu His Arg Thr
Leu His Thr Arg
Leu His Trp Ala
Leu Lys Cys Tyr
Leu Lys Glu His
Leu Lys His Glu
Leu Lys Tyr Cys
Leu Gln Glu His
C22H35N7O8 (525.2546990000001)
Leu Gln His Glu
C22H35N7O8 (525.2546990000001)
Leu Arg His Thr
Leu Arg Thr His
Leu Thr His Arg
Leu Thr Arg His
Leu Trp Ala His
Leu Trp His Ala
Leu Tyr Cys Lys
Leu Tyr Lys Cys
Met Phe Lys Thr
Met Phe Thr Lys
Met Lys Phe Thr
Met Lys Thr Phe
Met Thr Phe Lys
Met Thr Lys Phe
Asn Phe Phe Val
Asn Phe Val Phe
Asn His Lys Lys
Asn His Lys Gln
Asn His Gln Lys
Asn Lys His Lys
Asn Lys His Gln
Asn Lys Lys His
Asn Lys Gln His
Asn Gln His Lys
Asn Gln Lys His
Asn Val Phe Phe
Gln Glu His Ile
C22H35N7O8 (525.2546990000001)
Gln Glu His Leu
C22H35N7O8 (525.2546990000001)
Gln Glu Ile His
C22H35N7O8 (525.2546990000001)
Gln Glu Leu His
C22H35N7O8 (525.2546990000001)
Gln His Glu Ile
C22H35N7O8 (525.2546990000001)
Gln His Glu Leu
C22H35N7O8 (525.2546990000001)
Gln His Ile Glu
C22H35N7O8 (525.2546990000001)
Gln His Lys Asn
Gln His Leu Glu
C22H35N7O8 (525.2546990000001)
Gln His Asn Lys
Gln Ile Glu His
C22H35N7O8 (525.2546990000001)
Gln Ile His Glu
C22H35N7O8 (525.2546990000001)
Gln Lys His Asn
Gln Lys Asn His
Gln Leu Glu His
C22H35N7O8 (525.2546990000001)
Gln Leu His Glu
C22H35N7O8 (525.2546990000001)
Gln Asn His Lys
Gln Asn Lys His
Arg Asp His Val
Arg Asp Val His
Arg Phe Phe Gly
Arg Phe Gly Phe
Arg Gly Phe Phe
Arg His Asp Val
Arg His Ile Thr
Arg His Leu Thr
Arg His Thr Ile
Arg His Thr Leu
Arg His Val Asp
Arg Ile His Thr
Arg Ile Thr His
Arg Leu His Thr
Arg Leu Thr His
Arg Ser Thr Tyr
C22H35N7O8 (525.2546990000001)
Arg Ser Tyr Thr
C22H35N7O8 (525.2546990000001)
Arg Thr His Ile
Arg Thr His Leu
Arg Thr Ile His
Arg Thr Leu His
Arg Thr Ser Tyr
C22H35N7O8 (525.2546990000001)
Arg Thr Tyr Ser
C22H35N7O8 (525.2546990000001)
Arg Val Asp His
Arg Val His Asp
Arg Tyr Ser Thr
C22H35N7O8 (525.2546990000001)
Arg Tyr Thr Ser
C22H35N7O8 (525.2546990000001)
Ser Arg Thr Tyr
C22H35N7O8 (525.2546990000001)
Ser Arg Tyr Thr
C22H35N7O8 (525.2546990000001)
Ser Thr Arg Tyr
C22H35N7O8 (525.2546990000001)
Ser Thr Tyr Arg
C22H35N7O8 (525.2546990000001)
Ser Tyr Arg Thr
C22H35N7O8 (525.2546990000001)
Ser Tyr Thr Arg
C22H35N7O8 (525.2546990000001)
Thr Phe Lys Met
Thr Phe Met Lys
Thr His Leu Arg
Thr His Arg Ile
Thr His Arg Leu
Thr Ile His Arg
Thr Ile Arg His
Thr Lys Phe Met
Thr Lys Met Phe
Thr Leu His Arg
Thr Leu Arg His
Thr Met Phe Lys
Thr Met Lys Phe
Thr Arg His Ile
Thr Arg His Leu
Thr Arg Ile His
Thr Arg Leu His
Thr Arg Ser Tyr
C22H35N7O8 (525.2546990000001)
Thr Arg Tyr Ser
C22H35N7O8 (525.2546990000001)
Thr Ser Arg Tyr
C22H35N7O8 (525.2546990000001)
Thr Ser Tyr Arg
C22H35N7O8 (525.2546990000001)
Thr Tyr Arg Ser
C22H35N7O8 (525.2546990000001)
Thr Tyr Ser Arg
C22H35N7O8 (525.2546990000001)
Val Asp His Arg
Val Asp Arg His
Val Phe Phe Asn
Val Phe Asn Phe
Val His Asp Arg
Val His Arg Asp
Val Asn Phe Phe
Val Arg Asp His
Val Arg His Asp
Trp Ala His Ile
Trp Ala His Leu
Trp Ala Ile His
Trp Ala Leu His
Trp His Ala Ile
Trp His Ala Leu
Trp His Ile Ala
Trp His Leu Ala
Trp Ile Ala His
Trp Ile His Ala
Trp Leu Ala His
Trp Leu His Ala
Tyr Cys Ile Lys
Tyr Cys Lys Ile
Tyr Cys Lys Leu
Tyr Cys Leu Lys
Tyr Ile Cys Lys
Tyr Ile Lys Cys
Tyr Lys Cys Ile
Tyr Lys Cys Leu
Tyr Lys Ile Cys
Tyr Lys Leu Cys
Tyr Leu Cys Lys
Tyr Leu Lys Cys
Tyr Arg Ser Thr
C22H35N7O8 (525.2546990000001)
Tyr Arg Thr Ser
C22H35N7O8 (525.2546990000001)
Tyr Ser Arg Thr
C22H35N7O8 (525.2546990000001)
Tyr Ser Thr Arg
C22H35N7O8 (525.2546990000001)
Tyr Thr Arg Ser
C22H35N7O8 (525.2546990000001)
Tyr Thr Ser Arg
C22H35N7O8 (525.2546990000001)
PS(18:0/0:0)[U]
C24H48NO9P (525.3066527999999)
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
LPS O-18:1;O
C24H48NO9P (525.3066527999999)
Pentoxyverine Citrate
C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents Pentoxyverine (Carbetapentane) citrate is an orally active sigma-1 receptor agonist, with Kis of 41 nM, 894 nM and 75 nM for σ1, σ2 and guinea-pig brain membrane σ1, respectively. Pentoxyverine citrate is a muscarinic antagonist. Pentoxyverine citrate is a potent antitussive, anticonvulsant, and spasmolytic agent. Pentoxyverine citrate can be used for inhibiting bronchial interceptor, weakening of cough reflex, bronchial smooth muscle relaxation and reduction of airway resistance[1][2][3][4].
(6R,9R,12R)-6,9-dibenzyl-12-isobutyl-2,2-dimethyl-4,7,10-trioxo-3-oxa-5,8,11-triazatridecan-13-oic acid
Flovagatran
C27H36BN3O7 (525.2646176000001)
C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent
Selpercatinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159438 - RET Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
(E,3R,8S,9S,10R)-N-[(Z)-2-(3-chloro-4-hydroxyphenyl)ethenyl]-3,9-dihydroxy-2,4-dimethoxy-6,8,10-trimethyl-7-oxotetradec-5-enamide
C27H40ClNO7 (525.2493160000001)
2-cyclopropyl-1-[(3R)-3-(2-hydroxyethyl)-6-[(4-methyl-1-piperazinyl)-oxomethyl]-4-[3-(3-pyridinyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridin-2-yl]ethanone
C31H35N5O3 (525.2739760000001)
(2E,6E,12E)-19-(2-Amino-2-oxoethyl)-9,11-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxohenicosa-2,6,12-trienedioic acid
1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-(pyridin-4-ylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-pyridin-4-ylethanone
C31H35N5O3 (525.2739760000001)
N-[(2S,4aR,12aR)-2-[2-[(1,3-dimethylpyrazol-4-yl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide
N-[(5R,6R,9R)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-fluorobenzamide
N-[(2S,4aR,12aS)-2-[2-[(1,3-dimethylpyrazol-4-yl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide
N-[(5R,6S,9R)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-fluorobenzamide
N-[(4R,7R,8S)-5-[(4-fluorophenyl)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopentanecarboxamide
1-[(4R,7R,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(4R,7S,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
N-[(2R,4aR,12aS)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(5S,6R,9R)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-fluorobenzamide
N-[(5S,6R,9S)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-fluorobenzamide
N-[(5S,6S,9S)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-fluorobenzamide
N-[(5R,6R,9S)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-fluorobenzamide
2-[[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-14-(1-oxobutylamino)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-5-yl]methyl]benzoic acid
1-[(4R,7R,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(4S,7S,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(4S,7R,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(4S,7S,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(4R,7S,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(4S,7R,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
N-[(2S,4aS,12aS)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2S,4aS,12aR)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2R,4aR,12aR)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2R,4aS,12aR)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2R,4aS,12aS)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-(pyridin-4-ylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-pyridin-4-ylethanone
C31H35N5O3 (525.2739760000001)
N-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-sn-glycero-3-phosphoethanolamine
4-[[4-(diethylamino)phenyl]-(4-phenyliminonaphthalen-1-ylidene)methyl]-N,N-diethylaniline
[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
2-Amino-3-[hydroxy-(2-nonanoyloxy-3-octanoyloxypropoxy)phosphoryl]oxypropanoic acid
2-Amino-3-[(2-decanoyloxy-3-heptanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(2-dodecanoyloxy-3-pentanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[hydroxy-(3-propanoyloxy-2-tetradecanoyloxypropoxy)phosphoryl]oxypropanoic acid
2-Amino-3-[(3-hexanoyloxy-2-undecanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(3-butanoyloxy-2-tridecanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
3-[(3-Acetyloxy-2-pentadecanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid
lysophosphatidylethanolamine (0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as 4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl.
1-(2-methoxy-6Z-heptadecenyl)-sn-glycero-3-phosphoserine
C24H48NO9P (525.3066527999999)
lysophosphatidylethanolamine 22:6
An acyl-sn-glycero-3-phosphoethanolamine in which the acyl group contains twenty-two carbons with six double bonds and is attached to the glycero moiety at either position 1 or 2.
1-docosahexaenoyl-sn-glycero-3-phosphoethanolamine zwitterion
A 1-acyl-sn-glycero-3-phosphoethanolamine zwitterion obtained by transfer of a proton from the amino to the phosphate group of 1-docosahexaenoyl-sn-glycero-3-phosphoethanolamine; major species at pH 7.3.
lysophosphatidylethanolamine (22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
A 1-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as 4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl.
DTP3
DTP3 TFA is a potent and selective GADD45β/MKK7 inhibitor. DTP3 TFA targets an essential, cancer-selective cell-survival module downstream of the NF-κB pathway[1].